BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 38808060)

  • 1. Sweet complexity:
    Børud B; Koomey M
    Front Cell Infect Microbiol; 2024; 14():1407863. PubMed ID: 38808060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic, Functional, and Immunogenic Analyses of the
    Næss LM; Maugesten IS; Caugant DA; Kassu A; Aseffa A; Børud B
    J Bacteriol; 2023 Mar; 205(3):e0045822. PubMed ID: 36852982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sculpting the Bacterial
    Hadjineophytou C; Anonsen JH; Svingerud T; Mortimer TD; Grad YH; Scott NE; Koomey M
    mBio; 2022 Jun; 13(3):e0379721. PubMed ID: 35471082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic, structural, and antigenic analyses of glycan diversity in the O-linked protein glycosylation systems of human Neisseria species.
    Børud B; Aas FE; Vik A; Winther-Larsen HC; Egge-Jacobsen W; Koomey M
    J Bacteriol; 2010 Jun; 192(11):2816-29. PubMed ID: 20363948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic and Phenotypic Characterization of the
    Børud B; Bårnes GK; Brynildsrud OB; Fritzsønn E; Caugant DA
    J Bacteriol; 2018 Aug; 200(16):. PubMed ID: 29555702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a Unique Tetrasaccharide and Distinct Glycoproteome in the O-Linked Protein Glycosylation System of Neisseria elongata subsp. glycolytica.
    Anonsen JH; Vik Å; Børud B; Viburiene R; Aas FE; Kidd SW; Aspholm M; Koomey M
    J Bacteriol; 2016 Jan; 198(2):256-67. PubMed ID: 26483525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic determinants of genus-level glycan diversity in a bacterial protein glycosylation system.
    Hadjineophytou C; Anonsen JH; Wang N; Ma KC; Viburiene R; Vik Å; Harrison OB; Maiden MCJ; Grad YH; Koomey M
    PLoS Genet; 2019 Dec; 15(12):e1008532. PubMed ID: 31869330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease.
    Mubaiwa TD; Semchenko EA; Hartley-Tassell LE; Day CJ; Jennings MP; Seib KL
    Pathog Dis; 2017 Jul; 75(5):. PubMed ID: 28633281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase variation of DNA methyltransferases and the regulation of virulence and immune evasion in the pathogenic Neisseria.
    Seib KL; Jen FE; Scott AL; Tan A; Jennings MP
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28859312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomics identifies the genetic islands that distinguish Neisseria meningitidis, the agent of cerebrospinal meningitis, from other Neisseria species.
    Perrin A; Bonacorsi S; Carbonnelle E; Talibi D; Dessen P; Nassif X; Tinsley C
    Infect Immun; 2002 Dec; 70(12):7063-72. PubMed ID: 12438387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Frequency Changes in Pilin Glycosylation Patterns during
    Jen FE; Abrahams JL; Schulz BL; Lamelas A; Pluschke G; Jennings MP
    ACS Infect Dis; 2023 Aug; 9(8):1451-1457. PubMed ID: 37467082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subversion of nutritional immunity by the pathogenic Neisseriae.
    Cornelissen CN
    Pathog Dis; 2018 Feb; 76(1):. PubMed ID: 29045638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic neisseriae: surface modulation, pathogenesis and infection control.
    Virji M
    Nat Rev Microbiol; 2009 Apr; 7(4):274-86. PubMed ID: 19287450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel protein substrates of the phospho-form modification system in Neisseria gonorrhoeae and their connection to O-linked protein glycosylation.
    Anonsen JH; Egge-Jacobsen W; Aas FE; Børud B; Koomey M; Vik A
    Infect Immun; 2012 Jan; 80(1):22-30. PubMed ID: 22083701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Pilin Antigenic Variation in Neisseria meningitidis by Next-Generation Sequencing.
    Xu J; Seifert HS
    J Bacteriol; 2018 Nov; 200(22):. PubMed ID: 30181126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic consequences of Neisseria gonorrhoeae pilin glycan variation.
    Ghosh SK; Zhao J; Philogene MC; Alzaharani A; Rane S; Banerjee A
    Microbes Infect; 2004 Jun; 6(7):693-701. PubMed ID: 15158777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Bioinformatic Assessments of the Variability of Neisseria gonorrhoeae Vaccine Candidates.
    Baarda BI; Zielke RA; Holm AK; Sikora AE
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neisseria gonorrhoeae O-linked pilin glycosylation: functional analyses define both the biosynthetic pathway and glycan structure.
    Aas FE; Vik A; Vedde J; Koomey M; Egge-Jacobsen W
    Mol Microbiol; 2007 Aug; 65(3):607-24. PubMed ID: 17608667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neisseria proteomics for antigen discovery and vaccine development.
    Christodoulides M
    Expert Rev Proteomics; 2014 Oct; 11(5):573-91. PubMed ID: 25017717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.